FGFR2 and intrahepatic cholangiocarcinoma: Even though stratification by PTEN deficiency was not the first or the unique target in precise treatment for ICC, PTEN was undoubtedly a convenient single genetic biomarker at the protein level which is different from other targets such as FGFR2 fusions or IDH1 mutations.